Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

share with twitter share with LinkedIn share with facebook
03/23/2020 | 01:00pm EDT

DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Share buy-back
Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

23.03.2020 / 17:56
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Share buy-back - 40th Interim Report

In the period from March 16, 2020 until and including March 20, 2020, a total of 449,021 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange and via selected multilateral trading facilities (MTF):

XETRA

 Aggregated volume in Weighted average share number of shares price in EUR

Day of repurchase Aggregated volume in number of shares Weighted average share price in EUR
16.03.2020 344,779 56.40471
17.03.2020 9,953 59.2980
18.03.2020 9,187 58.8520
19.03.2020 3,000 58.3104
20.03.2020 990 57.3667
 

Chi-X Europe

Day of repurchase Aggregated volume in number of sharesAggregated volume in number of sharesAggregated volume in number of shares Weighted average share price in EUR
16.03.2020 57,482 56.57144
17.03.2020 - -
18.03.2020 - -
19.03.2020 - -
20.03.2020 - -
 

BATS Europe

Day of repurchase Aggregated volume in number of shares Weighted average share price in EUR
16.03.2020 9,652 56.4773
17.03.2020 - -
18.03.2020 - -
19.03.2020 - -
20.03.2020 - -
 

Turquoise

Day of repurchase Aggregated volume in number of shares Weighted average share price in EUR
16.03.2020 13,978 56.3285
17.03.2020 - -
18.03.2020 - -
19.03.2020 - -
20.03.2020 - -
 

The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including March 20, 2020 therefore amounts to 5,903,049 shares.

Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board

Bad Homburg v.d.H., March 23, 2020



23.03.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com

 
End of News DGAP News Service

1004339  23.03.2020 

fncls.ssp?fn=show_t_gif&application_id=1004339&application_name=news&site_id=zonebourse
© EQS 2020

share with twitter share with LinkedIn share with facebook
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
03:05aFRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 41 of the Wp..
EQ
10/30FRESENIUS MEDICAL CARE : continues solid revenue and strong earnings growth in t..
AQ
10/30FMC FRESENIUS MEDICAL CARE AG & CO K : Kepler Cheuvreux keeps its Buy rating
MD
10/30FMC FRESENIUS MEDICAL CARE AG & CO K : Buy rating from Independant Research
MD
10/30FMC FRESENIUS MEDICAL CARE AG & CO K : JP Morgan remains its Buy rating
MD
10/29FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 50 of the Wp..
EQ
10/29FRESENIUS SE : Berenberg maintains a Buy rating
MD
10/29FMC FRESENIUS MEDICAL CARE AG & CO K : Berenberg reiterates its Buy rating
MD
10/29FMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Buy rating from UBS
MD
10/29FMC FRESENIUS MEDICAL CARE AG & CO K : Warburg Research sticks Neutral
MD
More news
Financials (USD)
Sales 2020 21 307 M - -
Net income 2020 1 543 M - -
Net Debt 2020 13 866 M - -
P/E ratio 2020 14,6x
Yield 2020 1,76%
Capitalization 22 364 M 22 379 M -
EV / Sales 2020 1,70x
EV / Sales 2021 1,58x
Nbr of Employees 124 736
Free-Float 65,1%
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 96,13 $
Last Close Price 76,37 $
Spread / Highest target 50,3%
Spread / Average Target 25,9%
Spread / Lowest Target -16,8%
EPS Revisions
Managers
NameTitle
Rice Powell Chairman-Management Board
Dieter Schenk Chairman-Supervisory Board
Helen Giza Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer
Sector and Competitors